Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€59.50

€59.50

0.000%
-
0.000%
€62.03

€62.03

 
13.03.26 / Frankfurt WKN: 856744 / Symbol: CBT / Name: Cabot / Stock / Chemicals / Mid Cap /
Latest predictions
10.01.26
-6.35%
buy
08.01.26
-4.84%
buy
€68.15
18.12.25
4.39%
buy
€46.61
28.11.25
8.26%
€62.03
17.11.25
11.32%
buy
Best running prediction
€62.03
17.11.25
11.32%
buy
Your prediction

Cabot Corp. Stock

There is no change in the price for Cabot Corp. today.
Our community is currently high on Cabot Corp. with 4 Buy predictions and 1 Sell predictions.
As a result the target price of 62 € shows a slightly positive potential of 4.2% compared to the current price of 59.5 € for Cabot Corp..

Pros and Cons of Cabot Corp. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cabot Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cabot Corp. 0.000% -0.833% -7.031% -20.667% 6.250% -13.768% 35.227%
Innospec Inc. 0.000% -3.252% -17.931% -33.146% -9.848% - -
Sensient Technologies Corp. 0.000% 0.637% 0.637% 18.797% -1.250% 20.611% -
Stepan Co 0.500% -2.427% -27.568% -22.692% 1.005% -55.580% -62.430%

Comments

Cabot (NYSE:CBT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for CBT provided by MarketBeat
Show more

Cabot (NYSE:CBT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for CBT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.39%
Target price 68.152
Change
Ends at 18.12.26

Cabot (NYSE:CBT) had its price target raised by analysts at Mizuho from $72.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for CBT provided by MarketBeat
Show more